On July 24, 2017, Vice Minister of Healthcare of the Republic of Kazakhstan Lyatsat Aktayeva and Ambassador Extraordinary and Plenipotentiary of the Kingdom of Saudi Arabia in the Republic of Kazakhstan Dahir Bin Mutish Alainazi visited the Scientific Center of Pediatrics and Children's Surgery in Almaty.
Purpose of the visit: the transfer of medical equipment by the representatives of the Center for Humanitarian Assistance named after King Salman (Kingdom of Saudi Arabia) to the center. It is a magnetic resonance imager, an X-ray diagnostic digital apparatus and an ultrasound diagnostic tool in the kit that allows you to perform accurate diagnostics and obtain excellent image quality for any type of research.
This medical equipment will allow to further improve and speed up early diagnostics of diseases in children of different age categories, to shorten the time of examination, which is important for examining small patients, since the main share of sick children is children from 0 to 5 years. All this will give an opportunity as soon as possible to purposefully prescribe therapy and thus increase the chances of children to recover.
Annually, an average of 600 children with malignant neoplasms are first diagnosed in the republic for the first time. In recent years, thanks to advances in medicine, the life expectancy of children with cancer has been increasing, and a significant part of them has managed to achieve a practical recovery. These results are achieved to a large extent due to early diagnosis and timely treatment. Over the past year, there has been an improvement in the primary diagnosis of tumors in Kazakhstan at an early stage of the oncological process (in 2015 - 29%, 2016 - 37%).
Assistance to children with oncological and hematological diseases is carried out according to modern clinical protocols for diagnosis and treatment based on international programs for the therapy of tumors in children. This allowed to increase the survival rate of children with solid tumors and hemoblastoses. Thus, when using the German BFM program, survival of children with acute lymphoblastic leukemia increased to 76.3%, and in acute myeloblastic leukemia, to 42%.
In recent years, the Center has implemented a high-tech procedure for the transplantation of hematopoietic stem cells in the treatment of children with relapses of leukemia acquired by aplastic anemia and severe forms of solid tumors. This technology also showed effective results that meet modern international standards.

{gallery}News_24.07.2017{/gallery}